Alector (ALEC): Short-Term Debt to Equity Ratio

This daily price chart for Alector, Inc. (ALEC) on the GURU.Markets platform captured the 0.00 metric. The business relies on strategic alliances to advance its developments without direct asset acquisitions. Alector, Inc. (ALEC) develops treatments for dementia and tremors, allocating capital through collaborations with market leaders. High barriers to entry and R&D costs limit competition within this sector.

Alector, Inc. (ALEC) is investing significant resources into creating an immuno-neurology ecosystem to combat dementia. This indicator measures the share of short-term liabilities within the equity structure, reflecting the dependence on rapid financing. By analyzing the change in the ratio of current liabilities to equity, the investor sees the current value of 0.00, which determines the balance between expansion and liquidity. A low coefficient level confirms capital stability during the implementation of long-term scientific developments.